Motor control - page 3 Scientific Publications

Latest publication 10/15/2012

Genetic KCa3-1-Deficiency Produces Locomotor Hyperactivity and Alterations in Ce

Background The calmodulin/calcium-activated K+ channel KCa3.1 is expressed in red and white blood cells, epithelia and endothelia, and possibly...

Array
(
    [id_prestablog_news] => 457
    [id_shop] => 1
    [date] => 2012-10-15 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 895
    [id_lang] => 1
    [title] => Genetic KCa3-1-Deficiency Produces Locomotor Hyperactivity and Alterations in Ce
    [paragraph] => Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral Monoamine Levels
    [content] => 
Authors
K. L. Lambertsen, J. B. Gramsbergen, M. Sivasaravanaparan, N. Ditzel, L. M. Sevelsted-Møller, A. Oliván-Viguera.

 Lab
University of Southern Demark, Odense, Denmark.
Journal
PLoS ONE
Abstract
Background
The calmodulin/calcium-activated K+ channel KCa3.1 is expressed in red and white blood cells, epithelia and endothelia, and possibly central and peripheral neurons. However, our knowledge about its contribution to neurological functions and behavior is incomplete. Here, we investigated whether genetic deficiency or pharmacological activation of KCa3.1 change behavior and cerebral monoamine levels in mice.
Methodology/Principal Findings
In the open field test, KCa3.1-deficiency increased horizontal activity, as KCa3.1−/− mice travelled longer distances (≈145% of KCa3.1+/+) and at higher speed (≈1.5-fold of KCa3.1+/+). Working memory in the Y-maze was reduced by KCa3.1-deficiency. Motor coordination on the rotarod and neuromuscular functions were unchanged. In KCa3.1−/− mice, HPLC analysis revealed that turn-over rates of serotonin were reduced in frontal cortex, striatum and brain stem, while noradrenalin turn-over rates were increased in the frontal cortex. Dopamine turn-over rates were unaltered. Plasma catecholamine and corticosterone levels were unaltered. Intraperitoneal injections of 10 mg/kg of the KCa3.1/KCa2-activator SKA-31 reduced rearing and turning behavior in KCa3.1+/+ but not in KCa3.1−/− mice, while 30 mg/kg SKA-31 caused strong sedation in 50% of the animals of either genotypes. KCa3.1−/− mice were hyperactive (≈+60%) in their home cage and SKA-31-administration reduced nocturnal physical activity in KCa3.1+/+ but not in KCa3.1−/− mice.
Conclusions/Significance
KCa3.1-deficiency causes locomotor hyperactivity and altered monoamine levels in selected brain regions, suggesting a so far unknown functional link of KCa3.1 channels to behavior and monoaminergic neurotransmission in mice. The tranquilizing effects of low-dose SKA-31 raise the possibility to use KCa3.1/KCa2 channels as novel pharmacological targets for the treatment of neuropsychiatric hyperactivity disorders.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
    [meta_description] => 
    [meta_keywords] => http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047744
    [meta_title] => 
    [link_rewrite] => genetic-kca3-1-deficiency-produces-locomotor-hyperactivity-and-alterations-in-cerebral-monoamine-levels
    [actif_langue] => 1
    [read] => 1132
    [count_comments] => 0
    [id] => 457
    [categories] => Array
        (
            [24] => Array
                (
                    [id_prestablog_categorie] => 24
                    [title] => Cross-disciplinary subjects 
                    [link_rewrite] => Cross-disciplinary-subjects-
                )

            [88] => Array
                (
                    [id_prestablog_categorie] => 88
                    [title] => Genetics
                    [link_rewrite] => Genetics
                )

            [55] => Array
                (
                    [id_prestablog_categorie] => 55
                    [title] => Locomotion
                    [link_rewrite] => Locomotion
                )

            [14] => Array
                (
                    [id_prestablog_categorie] => 14
                    [title] => Motor control
                    [link_rewrite] => Motor-control
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Genetic KCa3.1-Deficiency Produces Locomotor Hyperactivity and Alterations in Cerebral [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://preprod.bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1